PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study

The treatment of diseases that affect the central nervous system (CNS) represents a great research challenge due to the restriction imposed by the blood–brain barrier (BBB) to allow the passage of drugs into the brain. However, the use of modified nanomedicines engineered with different ligands that...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmaceutics
Hlavní autoři: Hoyos-Ceballos, Gina P., Ruozi, Barbara, Ottonelli, Ilaria, Da Ros, Federica, Vandelli, Maria Angela, Forni, Flavio, Daini, Eleonora, Vilella, Antonietta, Zoli, Michele, Tosi, Giovanni, Duskey, Jason T., López-Osorio, Betty L.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7023215/
https://ncbi.nlm.nih.gov/pubmed/31963430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12010072
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky